Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY1R | P25929 | 1/20 | 0.53 |
| ▸ | NPY2R | P49146 | 1/20 | 0.53 |
| ▸ | NPY4R | P50391 | 1/20 | 0.53 |
| ▸ | MME | P08473 | 4/20 | 0.53 |
| ▸ | ACE | P12821 | 2/20 | 0.53 |
| ▸ | CPA1 | P15085 | 1/20 | 0.53 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.53 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.51 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.51 |
| ▸ | FNTA | P49354 | 3/20 | 0.50 |
| ▸ | FNTB | P49356 | 3/20 | 0.50 |
| ▸ | PGGT1B | P53609 | 3/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7609995 | 1.00 | NPY1R (0.53) | NPY1RNPY2RNPY4RMMEACE | |
| SCHEMBL29558363 | 0.93 | ENPEP (0.52) | NPY1RNPY2RNPY4RMMEACE | |
| SCHEMBL30311095 | 0.91 | ENPEP (0.57) | NPY1RNPY2RNPY4RNAALAD2FNTA | |
| SCHEMBL29794193 | 0.90 | FNTA (0.55) | FNTAFNTBPGGT1B | |
| SCHEMBL21828645 | 0.90 | FNTA (0.55) | FNTAFNTBPGGT1B | |
| SCHEMBL2549632 | 0.90 | FNTA (0.55) | FNTAFNTBPGGT1B | |
| SCHEMBL26417444 | 0.90 | NPY4R (0.53) | NPY1RNPY2RNPY4RACE | |
| SCHEMBL13154780 | 0.90 | FNTA (0.60) | MMEFNTAFNTBPGGT1B | |
| SCHEMBL9442969 | 0.90 | FNTA (0.60) | MMEFNTAFNTBPGGT1B | |
| SCHEMBL10696437 | 0.90 | FNTA (0.60) | MMEFNTAFNTBPGGT1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020071258-A1 | PROTEIN GLYCATION SUPPRESSANT | 味の素株式会社 | 2020-04-09 | — | — | WO | disclosed |
| EP-0678522-B1 | Insulin analogs | LILLY CO ELI (US) | 2002-01-02 | — | — | EP | disclosed |
| US-5700662-A | CULTURING A GENETIC ENGINEERED HOST CELL, GENE EXPRESSING A DNA, ENCODING A PROINSULIN, ENZYMATICALLY DISCONNECTING | ELI LILLY AND COMPANY (US) | 1997-12-23 | — | — | US | disclosed |
| US-5514646-A | AND OPTIONALLY AT OTHER POSITIONS; USE TO TREAT HYPERGLYCEMIA | ELI LILLY AND COMPANY | 1996-05-07 | — | — | US | disclosed |
| EP-0383472-B1 | Insulin analogs | LILLY CO ELI (US) | 1996-02-07 | — | — | EP | disclosed |
| EP-0678522-A1 | Insulin analogs | ELI LILLY AND COMPANY (US) | 1995-10-25 | — | — | EP | disclosed |
| EP-0383472-A2 | Insulin analogs | ELI LILLY AND COMPANY (US) | 1990-08-22 | — | — | EP | disclosed |
| EP-0127108-B1 | PROCESS FOR PREPARING POLYPEPTIDES | MERCK & CO. INC. (US) | 1986-12-30 | — | — | EP | disclosed |
| US-4510083-A | POTASSIUM, CESIUM OR RUBIDIUM CARBONATE BUFFER FOR COUPLING OF AMINO ACID N-CARBOXYANHYDRIDE WITH ANOTHER AMINO ACID OR PEPTIDE | MERCK & CO., INC. (US) | 1985-04-09 | — | — | US | disclosed |
| EP-0127108-A1 | Process for preparing polypeptides | MERCK & CO. INC. (US) | 1984-12-05 | — | — | EP | disclosed |